Influenza vaccination generates cytokine-induced memorylike NK cells: Impact of human cytomegalovirus infection

Journal of Immunology

Volumn 197, Issue 1, 2016, Pages 313-325

  Goodier, Martin R ^a   Rodriguez Galan, Ana ^a   Lusa, Chiara ^a   Nielsen, Carolyn M ^a   Darboe, Alansana ^a,b   Moldoveanu, Ana L ^a   White, Matthew J ^a   Behrens, Ron ^a   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 2; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INFLUENZA VACCINATION; INNATE IMMUNITY; MEMORY CELL; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEASONAL INFLUENZA; SINGLE DRUG DOSE; CELL CULTURE; COMPLICATION; CYTOMEGALOVIRUS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; ORTHOMYXOVIRIDAE; VACCINATION; YOUNG ADULT;

ADULT; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MIDDLE AGED; ORTHOMYXOVIRIDAE; VACCINATION; YOUNG ADULT;

EID: 84975231513     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502049     Document Type: Article

References (50)

1. Netea, M. G., E. Latz, K. H. Mills, and L. A. O'Neill. 2015. Innate immune memory: A paradigm shift in understanding host defense. Nat. Immunol. 16: 675-679.
2. Netea, M. G., J. Quintin, and J. W. van der Meer. 2011. Trained immunity: A memory for innate host defense. Cell Host Microbe 9: 355-361.
3. Sato, M., M. Hosoya, and P. F. Wright. 2009. Differences in serum cytokine levels between influenza virus A and B infections in children. Cytokine 47: 65-68.
4. Dunmire, S. K., O. A. Odumade, J. L. Porter, J. Reyes-Genere, D. O. Schmeling, H. Bilgic, D. Fan, E. C. Baechler, H. H. Balfour, Jr., and K. A. Hogquist. 2014. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS One 9: e85422.
5. Stacey, A. R., P. J. Norris, L. Qin, E. A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, D. Grove, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83: 3719-3733.
6. van de Berg, P. J., K. M. Heutinck, R. Raabe, R. C. Minnee, S. L. Young, K. A. van Donselaar-van der Pant, F. J. Bemelman, R. A. van Lier, and I. J. ten Berge. 2010. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J. Infect. Dis. 202: 690-699.
7. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
8. Romee, R., S. E. Schneider, J. W. Leong, J. M. Chase, C. R. Keppel, R. P. Sullivan, M. A. Cooper, and T. A. Fehniger. 2012. Cytokine activation induces human memory-like NK cells. Blood 120: 4751-4760.
9. Berrien-Elliott, M. M., J. A. Wagner, and T. A. Fehniger. 2015. Human Cytokine-Induced Memory-Like Natural Killer Cells. J. Innate Immun. 7: 563-571.
10. Rydyznski, C. E., and S. N. Waggoner. 2015. Boosting vaccine efficacy the natural (killer) way. Trends Immunol. 36: 536-546.
11. Keppel, M. P., L. Yang, and M. A. Cooper. 2013. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J. Immunol. 190: 4754-4762.
12. Lee, S. H., S. Yun, Z. H. Piao, M. Jeong, D. O. Kim, H. Jung, J. Lee, M. J. Kim, M. S. Kim, J.W. Chung, et al. 2010. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. J. Immunol. 185: 917-928.
13. Tang, F., B. Sally, C. Ciszewski, V. Abadie, S. A. Curran, V. Groh, O. Fitzgerald, R. J. Winchester, and B. Jabri. 2013. Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis. PLoS One 8: e76292.
14. Vallera, D. A., M. Felices, R. T. McElmurry, V. McCullar, X. Zhou, J. Schmohl, B. Zhang, A. Lenvik, A. Panoskaltsis-Mortari, M. R. Verneris, et al. 2016. IL-15 Trispecific Killer Engagers (TriKEs) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing In Vivo Expansion, and Enhanced Function. Clin. Cancer Res. DOI: 10.1158/1078-0432.CCR-15-2710.
15. Hagau, N., A. Slavcovici, D. N. Gonganau, S. Oltean, D. S. Dirzu, E. S. Brezoszki, M. Maxim, C. Ciuce, M. Mlesnite, R. L. Gavrus, et al. 2010. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit. Care 14: R203.
16. Mooij, P., G. Koopman, D. Mortier, M. van Heteren, H. Oostermeijer, Z. Fagrouch, R. de Laat, G. Kobinger, Y. Li, E. J. Remarque, et al. 2015. Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets. PLoS One 10: e0126132.
17. Wang, S. M., Y. T. Liao, Y. S. Hu, T. S. Ho, C. F. Shen, J. R. Wang, Y. S. Lin, and C. C. Liu. 2014. Immunophenotype expressions and cytokine profiles of influenza A H1N1 virus infection in pediatric patients in 2009. Dis. Markers 2014: 195453.
18. Arts, R. J., B. A. Blok, P. Aaby, L. A. Joosten, D. de Jong, J. W. van der Meer, C. S. Benn, R. van Crevel, and M. G. Netea. 2015. Long-term in vitro and in vivo effects of g-irradiated BCG on innate and adaptive immunity. J. Leukoc. Biol. 98: 995-1001.
19. Blok, B. A., R. J. Arts, R. van Crevel, C. S. Benn, and M. G. Netea. 2015. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. J. Leukoc. Biol. 98: 347-356.
20. Leong, J. W., J. M. Chase, R. Romee, S. E. Schneider, R. P. Sullivan, M. A. Cooper, and T. A. Fehniger. 2014. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol. Blood Marrow Transplant. 20: 463-473.
21. Ni, J., M. Miller, A. Stojanovic, N. Garbi, and A. Cerwenka. 2012. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 209: 2351-2365.
22. Jost, S., H. Quillay, J. Reardon, E. Peterson, R. P. Simmons, B. A. Parry, N. N. Bryant, W. D. Binder, and M. Altfeld. 2011. Changes in cytokine levels and NK cell activation associated with influenza. PLoS One 6: e25060.
23. Horowitz, A., R. H. Behrens, L. Okell, A. R. Fooks, and E. M. Riley. 2010. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185: 2808-2818.
24. Jost, S., P. J. Tomezsko, K. Rands, I. Toth, M. Lichterfeld, R. T. Gandhi, and M. Altfeld. 2014. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination. J. Virol. 88: 8349-8354.
25. Nielsen, C. M., M. J. White, C. Bottomley, C. Lusa, A. Rodríguez-Galán, S. E. Turner, M. R. Goodier, and E. M. Riley. 2015. Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals. J. Immunol. 194: 4657-4667.
26. White, M. J., C. M. Nielsen, R. H. McGregor, E. H. Riley, and M. R. Goodier. 2014. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology 142: 140-150.
27. Luetke-Eversloh, M., Q. Hammer, P. Durek, K. Nordström, G. Gasparoni, M. Pink, A. Hamann, J. Walter, H. D. Chang, J. Dong, and C. Romagnani. 2014. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 10: e1004441.
28. Goodier, M. R., M. J. White, A. Darboe, C. M. Nielsen, A. Goncalves, C. Bottomley, S. E. Moore, and E. M. Riley. 2014. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 124: 2213-2222.
29. Lefevre, E. A., B. V. Carr, C. F. Inman, H. Prentice, I. H. Brown, S. M. Brookes, F. Garcon, M. L. Hill, M. Iqbal, R. A. Elderfield, et al; COSI. 2012. Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes. PLoS One 7: e32400.
30. Barría, M. I., J. L. Garrido, C. Stein, E. Scher, Y. Ge, S. M. Engel, T. A. Kraus, D. Banach, and T. M. Moran. 2013. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J. Infect. Dis. 207: 115-124.
31. Nielsen, C. M., M. J. White, M. R. Goodier, and E. M. Riley. 2013. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease. Front. Immunol. 4: 422.
32. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
33. Lopez-Vergès, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
34. Muntasell, A., C. Vilches, A. Angulo, and M. López-Botet. 2013. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: A different perspective of the host-pathogen interaction. Eur. J. Immunol. 43: 1133-1141.
35. Dou, Y., B. Fu, R. Sun, W. Li, W. Hu, Z. Tian, and H. Wei. 2015. Influenza vaccine induces intracellular immune memory of human NK cells. PLoS One 10: e0121258.
36. Madera, S., M. Rapp, M. A. Firth, J. N. Beilke, L. L. Lanier, and J. C. Sun. 2016. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J. Exp. Med. 213: 225-233.
37. Hwang, I., J. M. Scott, T. Kakarla, D. M. Duriancik, S. Choi, C. Cho, T. Lee, H. Park, A. R. French, E. Beli, et al. 2012. Activation mechanisms of natural killer cells during influenza virus infection. PLoS One 7: e51858.
38. Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178: 2688-2698.
39. Braun, M., N. K. Björkström, S. Gupta, K. Sundström, C. Ahlm, J. Klingström, and H. G. Ljunggren. 2014. NK cell activation in human hantavirus infection explained by virus-induced IL-15/IL15Ra expression. PLoS Pathog. 10: e1004521. Available at: http://journals.plos.org/plospathogens/article?id=10. 1371/journal.ppat.1004521.
40. Mota, G., M. Manciulea, E. Cosma, I. Popescu, M. Hirt, E. Jensen-Jarolim, A. Calugaru, C. Galatiuc, T. Regalia, D. Tamandl, et al. 2003. Human NK cells express Fc receptors for IgA which mediate signal transduction and target cell killing. Eur. J. Immunol. 33: 2197-2205.
41. Marquardt, N., M. A. Ivarsson, K. Blom, V. D. Gonzalez, M. Braun, K. Falconer, R. Gustafsson, A. Fogdell-Hahn, J. K. Sandberg, and J. Michaëlsson. 2015. The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education. J. Immunol. 195: 3262-3272.
42. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K. J. Malmberg, J. Klingström, C. Ahlm, and H. G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
43. Béziat, V., O. Dalgard, T. Asselah, P. Halfon, P. Bedossa, A. Boudifa, B. Hervier, I. Theodorou, M. Martinot, P. Debré, et al. 2012. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
44. Gumá, M., M. Budt, A. Sáez, T. Brckalo, H. Hengel, A. Angulo, and M. López-Botet. 2006. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107: 3624-3631.
45. Rölle, A., J. Pollmann, E. M. Ewen, V. T. Le, A. Halenius, H. Hengel, and A. Cerwenka. 2014. IL-12-producing monocytes and HLA-E control HCMVdriven NKG2C+ NK cell expansion. J. Clin. Invest. 124: 5305-5316.
46. Lee, J., T. Zhang, I. Hwang, A. Kim, L. Nitschke, M. Kim, J. M. Scott, Y. Kamimura, L. L. Lanier, and S. Kim. 2015. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42: 431-442.
47. Zhang, T., J. M. Scott, I. Hwang, and S. Kim. 2013. Cutting edge: antibodydependent memory-like NK cells distinguished by FcRg deficiency. J. Immunol. 190: 1402-1406.
48. Lee, S. H., M. F. Fragoso, and C. A. Biron. 2012. Cutting edge: A novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J. Immunol. 189: 2712-2716.
49. Min-Oo, G., and L. L. Lanier. 2014. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J. Exp. Med. 211: 2669-2680.
50. Luetke-Eversloh, M., B. B. Cicek, F. Siracusa, J. T. Thom, A. Hamann, S. Frischbutter, R. Baumgrass, H. D. Chang, A. Thiel, J. Dong, and C. Romagnani. 2014. NK cells gain higher IFN-g competence during terminal differentiation. Eur. J. Immunol. 44: 2074-2084.